Abbott Labs (ABT) Stock Tumbles 8% as Weak Nutrition Sales Offset Strong Device Growth
TLDR Abbott Laboratories shares fell 8% after Q4 revenue of $11.5 billion came in below the $11.8 billion analyst estimate Nutrition segment sales declined 8.9%...












